Biochemist to receive $500,000 MacArthur grant for genius in drug research

September 20, 2005

Washington, D.C. September 13, 2005 . . . . A biochemist will receive a 2005 MacArthur Fellowship for work in ways to produce and discover better drugs via "molecular evolution." The grants, awarded by the John D. and Catherine T. MacArthur Foundation, will be announced publicly on Tuesday, September 20th. The name of the awardee and background material will be available on a password protected website on Friday, September 16 (see info below).

Awarded to talented individuals in a variety of fields who have shown exceptional originality in and dedication to their creative pursuits, MacArthur Fellows receive $500,000 grants that are bestowed with no conditions - recipients may use the money as they see fit. Nominated anonymously by leaders in their respective fields and never notified of their candidacy, the recipients will learn of their selection only when they receive a call from the MacArthur Foundation to notify them of their selection.
-end-
Reporters covering the story MUST abide by the September 20 embargo, the date for the official Fellows announcement.

Here is the password and user ID to access the Fellows website which will be live on Friday, September 16. URL: macarthurfellows.org; User ID: mac909; password: 2fell5.

The website will have the names and backgrounds of the winners available. You may contact the awardee directly, on or after September 16. If you need the telephone number, contact Vicki Robb at 202-457-8100. Available for interviews: Call Vicki Robb, 202-457-8100 to schedule.
  • Dan Socolow, program officer for the Fellows program at the MacArthur Foundation.
  • The Fellow, name to be available on the Fellows' website Friday, September 16. Call Vicki Robb for the telephone number, if needed.

    Lipman Hearne

    Related Drugs Articles from Brightsurf:

    The danger of Z-drugs for dementia patients
    Strong sleeping pills known as 'Z-drugs' are linked with an increased risk of falls, fractures and stroke among people with dementia, according to new research.

    Wallflowers could lead to new drugs
    Plant-derived chemicals called cardenolides - like digitoxin - have long been used to treat heart disease, and have shown potential as cancer therapies.

    Bristol pioneers use of VR for designing new drugs
    Researchers at the University of Bristol are pioneering the use of virtual reality (VR) as a tool to design the next generation of drug treatments.

    Towards better anti-cancer drugs
    The Bayreuth biochemist Dr. Claus-D. Kuhn and his research team have deciphered how the important human oncogene CDK8 is activated in cells of healthy individuals.

    Separating drugs with MagLev
    The composition of suspicious powders that may contain illicit drugs can be analyzed using a quick and simple method called magneto-Archimedes levitation (MagLev), according to a new study published in the journal Angewandte Chemie.

    People are more likely to try drugs for the first time during the summer
    American teenagers and adults are more likely to try illegal or recreational drugs for the first time in the summer, a new study shows.

    Drugs used to enhance sexual experiences, especially in UK
    Combining drugs with sex is common regardless of gender or sexual orientation, reveals new research by UCL and the Global Drug Survey into global trends of substance-linked sex.

    Promising new drugs for old pathogen Mtb
    UConn researchers are targeting a metabolic pathway, the dihydrofolate reductase pathway, crucial for amino acid synthesis to treat TB infections.

    Can psychedelic drugs heal?
    Many people think of psychedelics as relics from the hippie generation or something taken by ravers and music festival-goers, but they may one day be used to treat disorders ranging from social anxiety to depression, according to research presented at the annual convention of the American Psychological Association.

    New uses for existing antiviral drugs
    Broad-spectrum antiviral drugs work against a range of viral diseases, but developing them can be costly and time consuming.

    Read More: Drugs News and Drugs Current Events
  • Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.